Vifor Pharma Ltd., 10% Owner at ChemoCentryx, Inc. (CCXI), sold 257,353 shares at $53.37 ($13.8M) on 2020-07-30, disclosed to the SEC on 2020-08-03.
Open-market sale of $13.8M CCXI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.37 | 1,156 | $62K | 0.4% |
| 2 | $53.37 | 1,156 | $62K | 0.4% |
| 3 | $54.43 | 24,458 | $1.3M | 9.6% |
| 4 | $54.43 | 24,458 | $1.3M | 9.6% |
| 5 | $54.85 | 22,467 | $1.2M | 8.9% |
| 6 | $54.85 | 22,467 |
| $1.2M |
| 8.9% |
| 7 | $51.74 | 10,009 | $518K | 3.8% |
| 8 | $51.74 | 10,009 | $518K | 3.8% |
| 9 | $52.57 | 29,699 | $1.6M | 11.3% |
| 10 | $52.57 | 29,699 | $1.6M | 11.3% |
| 11 | $54.33 | 694 | $38K | 0.3% |
| 12 | $52.92 | 785 | $42K | 0.3% |
| 13 | $53.62 | 31,823 | $1.7M | 12.4% |
| 14 | $53.62 | 31,823 | $1.7M | 12.4% |
| 15 | $54.58 | 16,650 | $909K | 6.6% |
| Total | $53.66 avg | 257,353 | $13.8M | 100% |